Abi Jenkins

579 citations
19 papers · 348 indexed · h-index 10

Abi Jenkins

17 papers receiving 339 citations

Peers

Abi Jenkins
Comparison fields: 5 of 78
  • Applied Microbiology and Biotechnology 70
  • Molecular Medicine 64
  • Clinical Biochemistry 74
  • Pharmacology 131
  • Infectious Diseases 101
Replace D. Matthew Shoemaker with:
D. Matthew Shoemaker United States
Dominique Navas France
Liesbet De Bus Belgium
Brian M Hoff United States
Wiesława Duszyńska Poland
Sean Nguyen United States
Laura Whitney United Kingdom
Matthew F. Wack United States
Kristi Kuper United States
Yong Kyun Kim South Korea
Abi Jenkins relative to D. Matthew Shoemaker United States D. Matthew Shoemaker's profile →
Citations per field
00.5×5.6×
D. Matthew Shoemaker · 1×
Citations per year

Countries citing papers authored by Abi Jenkins

Since Specialization
Citations

This map shows the geographic impact of Abi Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abi Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abi Jenkins more than expected).

Fields of papers citing papers by Abi Jenkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abi Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abi Jenkins. The network helps show where Abi Jenkins may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Abi Jenkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Abi Jenkins Line = papers co-authored together Abi Jenkins links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20240
2 20240
3 20236
4 20236
5 20225
6 20221
7 20224
8 202127
9 202112
10 2021106
11 202115
12 201921
13 201829
14 20189
15 20173
16 201626
17 201655
18 201518
19 20065

About Abi Jenkins

Abi Jenkins is a scholar working on Applied Microbiology and Biotechnology, Pharmacology and Geriatrics and Gerontology, having authored 19 papers that have together received 348 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmaceutical studies and practices (3 papers), Pneumonia and Respiratory Infections (2 papers), Antibiotic Resistance in Bacteria (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Global Maternal and Child Health (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (70 citations), Molecular Medicine (64 citations) and Clinical Biochemistry (74 citations). Abi Jenkins has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Nicholas M. Brown, Carolyne Horner, Anna L. Goodman, Erwin Brown, C Jamieson, Alasdair MacGowan, Alison H. Thomson, Phil Wiffen, Andrew Lovering and Dilip Nathwani. Their work appears in journals such as British journal of surgery, Journal of Antimicrobial Chemotherapy and Journal of Hospital Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026